University officials admit data withheld from review panel before misconduct charges arose.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
The failure of protein cancer biomarkers to reach the clinic: why, and what can be done to address the problem?
BMC Medicine Open Access 09 August 2012
-
Adventures in data citation: sorghum genome data exemplifies the new gold standard
BMC Research Notes Open Access 02 July 2012
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Potti, A. et al. Nature Med. 12, 1294-1300 (2006).
Hsu, D. S. et al. J. Clin. Oncol. 25, 4350-4357 (2007).
Coombes, K. R., Wang, J. & Baggerly, K. A. Nature Med. 13, 1276-1277 (2007).
Baggerly, K. A. & Coombes, K. R. Ann. Appl. Stat. 3, 1309-1334 (2009).
Zaas, A. K. et al. Cell Host Microbe 6, 207-217 (2009).
Related links
Related links
Related external links
Institute of Medicine study of omics-based tests in clinical trials
Rights and permissions
About this article
Cite this article
Samuel Reich, E. Cancer trial errors revealed. Nature 469, 139–140 (2011). https://doi.org/10.1038/469139a
Published:
Issue Date:
DOI: https://doi.org/10.1038/469139a
This article is cited by
-
Proteome signatures—how are they obtained and what do they teach us?
Applied Microbiology and Biotechnology (2015)
-
The failure of protein cancer biomarkers to reach the clinic: why, and what can be done to address the problem?
BMC Medicine (2012)
-
Adventures in data citation: sorghum genome data exemplifies the new gold standard
BMC Research Notes (2012)
